Effects of nesiritide and dobutamine on heart rate variability in patients with decompensated heart failure

被引:0
|
作者
Aronson, D
Horton, DP
Burger, AJ
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Rambam Med Ctr, Haifa, Israel
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:101A / 101A
页数:1
相关论文
共 50 条
  • [1] Beneficial effect of nesiritide on heart rate variability in decompensated heart failure
    Burger, A
    HEART DISEASE: PATHOGENESIS, DIAGNOSIS AND TREATMENT, 2003, : 381 - 386
  • [2] Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure
    Aronson, D
    Burger, AJ
    AMERICAN HEART JOURNAL, 2004, 148 (05)
  • [3] Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure
    Gerhard, T
    Zineh, I
    Winterstein, AG
    Hartzema, AG
    PHARMACOTHERAPY, 2006, 26 (01): : 34 - 43
  • [4] Economic implications of Nesiritide versus Dobutamine in the treatment of patients with acutely decompensated congestive heart failure
    de Lissovoy, G
    Stier, DM
    Ciesla, G
    Munger, M
    Burger, AJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (05): : 631 - 633
  • [5] Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
    O'Connor, C. M.
    Starling, R. C.
    Hernandez, A. F.
    Armstrong, P. W.
    Dickstein, K.
    Hasselblad, V.
    Heizer, G. M.
    Komajda, M.
    Massie, B. M.
    McMurray, J. J. V.
    Nieminen, M. S.
    Reist, C. J.
    Rouleau, J. L.
    Swedberg, K.
    Adams, K. F., Jr.
    Anker, S. D.
    Atar, D.
    Battler, A.
    Botero, R.
    Bohidar, N. R.
    Butler, J.
    Clausell, N.
    Corbalan, R.
    Costanzo, M. R.
    Dahlstrom, U.
    Deckelbaum, L. I.
    Diaz, R.
    Dunlap, M. E.
    Ezekowitz, J. A.
    Feldman, D.
    Felker, G. M.
    Fonarow, G. C.
    Gennevois, D.
    Gottlieb, S. S.
    Hill, J. A.
    Hollander, J. E.
    Howlett, J. G.
    Hudson, M. P.
    Kociol, R. D.
    Krum, H.
    Laucevicius, A.
    Levy, W. C.
    Mendez, G. F.
    Metra, M.
    Mittal, S.
    Oh, B. -H.
    Pereira, N. L.
    Ponikowski, P.
    Wilson, W. H.
    Tanomsup, S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (01): : 32 - 43
  • [6] Nesiritide for decompensated congestive heart failure
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2001, 43 (1118): : 100 - 101
  • [7] Nesiritide in Acute Decompensated Heart Failure
    Kramer, Daniel B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (16): : 1547 - 1547
  • [8] Nesiritide for the treatment of decompensated heart failure
    Colucci, WS
    JOURNAL OF CARDIAC FAILURE, 2001, 7 (01) : 92 - 100
  • [9] Mortality and length of hospital stay in patients receiving dobutamine, milrinone, or nesiritide for acute decompensated heart failure
    Arnold, LM
    Carroll, NV
    Oinonen, M
    Crouch, MA
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S103 - S103
  • [10] Circadian Comparison of Heart Rate Variability Parameters in Patients with Decompensated Heart Failure
    de Oliveira Gomes, Bruno Ferraz
    Benchimol Barbosa, Paulo Roberto
    Nadal, Jurandir
    XXVI BRAZILIAN CONGRESS ON BIOMEDICAL ENGINEERING, CBEB 2018, VOL. 2, 2019, 70 (02): : 103 - 107